Status:

COMPLETED

Transcaval Access for Transcatheter Aortic Valve Replacement in People With No Good Options for Aortic Access

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Aortic Valve Stenosis

Eligibility:

All Genders

21-99 years

Phase:

PHASE1

Brief Summary

Background: \- Some people who need a transcatheter aortic valve replacement (TAVR) have leg arteries that are too small and are too sick for standard techniques. But they may benefit from a new tech...

Detailed Description

Transcaval access to the abdominal aorta from the neighboring inferior vena cava (IVC) has enabled transcatheter aortic valve replacement (TAVR) in a small number of patients who have no good options ...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Adults age greater than or equal to 21 years
  • Severe symptomatic de novo aortic valve stenosis or bioprosthetic aortic valve failure for which transcatheter aortic valve replacement (TAVR) is felt beneficial according to the consensus of the institutional multidisciplinary heart team
  • Extreme risk or inoperability for TAVR via conventional femoral artery, trans-apical, or trans-aortic access in the determination of the multidisciplinary heart team. This determination includes an in-person consultation by at least one cardiac surgeon member of the heart team.
  • Anatomic eligibility for caval-aortic TAVR, graded as favorable or feasible based on NHLBI core lab assessment of the baseline CT examination.
  • EXCLUSION CRITERIA:
  • Unable or unwilling to consent to participate
  • Anatomic eligibility for caval-aortic TAVR graded as unfavorable based on NHLBI core lab assessment of the baseline CT examination
  • Unlikely to benefit from caval-aortic TAVR
  • Pregnancy or intent to become pregnant prior to completion of all protocol follow-up requirements.

Exclusion

    Key Trial Info

    Start Date :

    October 30 2014

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 28 2018

    Estimated Enrollment :

    172 Patients enrolled

    Trial Details

    Trial ID

    NCT02280824

    Start Date

    October 30 2014

    End Date

    December 28 2018

    Last Update

    February 15 2019

    Active Locations (15)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 4 (15 locations)

    1

    Medstar Washington Hospital Center

    Washington D.C., District of Columbia, United States, 20010

    2

    Emory University

    Atlanta, Georgia, United States, 30322-1102

    3

    NorthShore University HealthSystem, Evanston Hospital

    Evanston, Illinois, United States, 60201

    4

    Advocate Heart Institute

    Oakbrook Terrace, Illinois, United States, 60181